Further, Wang and colleagues depicted that IL6 pretreatment of CD133+/CD44+ cells assisted in entering into the cell cycle in quiescent lung cancer stem cells and significantly increased chemosensitivity [52]. The gene discussed is PROM1; the disease is lung cancer.